EIF4A2 and bladder transitional cell carcinoma: In recent years, several studies have focused on the role of EIF4A2 in regulating immune responses and numerous cellular and pathophysiological processes, which serves as a prognostic biomarker and is correlated with immune infiltration in multiple cancers, including BLCA (46, 47).